InChi: InChI=1S/C22H24N4O4/c1-26(2)9-10-28-20-11-15(16-12-23-24-13-16)7-8-17(20)25-22(27)21-14-29-18-5-3-4-6-19(18)30-21/h3-8
Smiles: CC[C@H](C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H]([NH2+]C)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C4CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C
is a potent and selective bone morphogenetic protein receptor (BMP) inhibitor that inhibits ALK1 and ALK2 with IC50 values of 46 and 32 nM
Palmitic acid suppresses apolipoprotein M gene expression via the pathway of PPARβ/δ in HepG2 cells
Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death
Nepafenac D5 Catalog No.:M8226-2 InChi: InChI=1S/C22H24N4O4/c1-26(2)9-10-28-20-11-15(16-12-23-24-13-16)7-8-17(20)25-22(27)21-14-29-18-5-3-4-6-19(18)30-21/h3-8Nepafenac D5 (AHR 9434 D5) is the deuterium labeled Nepafenac, which is a selective COX 2 inhibitor. Product information CAS Number: 1246814 53 8 Molecular Weight: 259. 31 Formula: C15H14N2O2 Synonym: AHR 9434 D5 AL 6515 D5 Nevanac D5 Chemical Name: 2 {2 amino 3 [(2,3,4,5,6 H)benzoyl]phenyl}acetamide Smiles: [2H]C1=C(C(=O)C2=CC=CC(CC(N)=O)=C2N)C([2H])=C([2H])C([2H])=C1[2H] InChiKey: QEFAQIPZVLVERP XFEWCBMOSA N InChi: InChI=1S C15H14N2O2 c16 13(18)9 11